Investor Type | Firm |
Type of Fund | Venture Capital Fund |
Industries | Software (Web Marketplace Saas..) • IT (& TMT) • BioTech • Hardware (& Manufacturing) • Medical Devices (& Hospital Services) |
Stages | Seed, Startup, Early Stage |
Investing | United States • Korea |
Investment Range | $500,000 - $2,000,000 |
Assets Under Management | $500,000,000 |
Hyundai Venture Investment Corporation is a Venture Capital Fund that specializes in investing in various sectors including Software (such as Web Marketplace, SaaS, etc.), IT & TMT (Technology, Media, and Telecom), BioTech, Hardware & Manufacturing, and Medical Devices & Hospital Services. With assets under management of $500,000,000, they focus on equity investments with a minimum investment size of $500,000 and a maximum of $2,000,000, targeting the Seed, Startup, and Early Stage ventures. They position themselves as not just funders but as active partners that assist in early-stage challenges such as hiring, strategic focus, technical development, sales, and business partnerships. Their approach prioritizes firmness with teams that demonstrate integrity, transparency, and deep market and technical knowledge. They value founders who think differently and have the boldness to dream big. Hyundai Venture Investment Corporation takes a hands-on approach with portfolio companies, contributing meaningful insights and support based on their extensive operating experience as company founders and their broad network in digital health. They seek opportunities in markets ripe for disruption with a massive upside and invest in companies with unique, data-driven, and defensible technology, typically in the realm of digital health that converges their expertise in healthcare and technology. Their investment team is composed of former entrepreneurs with expertise in scientific, engineering, and medical fields, dedicated to driving innovation in the healthcare and technology sectors. Hyundai Venture Investment Corporation collaborates with other top-tier venture capital firms for later-stage capital raising for their portfolio companies and is committed to building transformative companies that aim to change the world.